Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma

By            

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 59-63

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma

By He Guoping   Zhao Baojian   Zhang Xu   Gong Rixiang  

Oncology Letters, Vol. 7, Iss. 2, 2014-02 ,pp. : 439-443

Spandidos Publications

Access to resources Recommend Favorite

BRAF mutation is not predictive of long‐term outcome in papillary thyroid carcinoma

By  

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 791-799

John Wiley & Sons Inc

Access to resources Recommend Favorite

Emerging targeted therapies for melanoma treatment (Review)

By Russo Angela   Ficili Bartolomea   Candido Saverio   Pezzino Franca Maria   Guarneri Claudio   Biondi Antonio   Travali Salvatore   McCubrey James A.   Spandidos Demetrios A.   Libra Massimo  

International Journal of Oncology, Vol. 45, Iss. 2, 2014-08 ,pp. : 516-524

Spandidos Publications

Access to resources Recommend Favorite

Germline and somatic mutations of the APC gene in papillary thyroid carcinoma associated with familial adenomatous polyposis: Analysis of three cases and a review of the literature

By              

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2239-2243

Spandidos Publications

Access to resources Recommend Favorite